| Literature DB >> 16492763 |
Simon P Graham1, Roger Pellé, Yoshikazu Honda, Duncan M Mwangi, Nyerhovwo J Tonukari, Mat Yamage, E Jane Glew, Etienne P de Villiers, Trushar Shah, Richard Bishop, Evelyne Abuya, Elias Awino, James Gachanja, Anthony E Luyai, Ferdinand Mbwika, Anthony M Muthiani, David M Ndegwa, Moses Njahira, John K Nyanjui, Fredrick O Onono, Julius Osaso, Rosemary M Saya, Claude Wildmann, Claire M Fraser, Ian Maudlin, Malcolm J Gardner, Subhash P Morzaria, Sheena Loosmore, Sarah C Gilbert, Jean-Christophe Audonnet, Pierre van der Bruggen, Vishvanath Nene, Evans L N Taracha.
Abstract
East Coast fever, caused by the tick-borne intracellular apicomplexan parasite Theileria parva, is a highly fatal lymphoproliferative disease of cattle. The pathogenic schizont-induced lymphocyte transformation is a unique cancer-like condition that is reversible with parasite removal. Schizont-infected cell-directed CD8(+) cytotoxic T lymphocytes (CTL) constitute the dominant protective bovine immune response after a single exposure to infection. However, the schizont antigens targeted by T. parva-specific CTL are undefined. Here we show the identification of five candidate vaccine antigens that are the targets of MHC class I-restricted CD8(+) CTL from immune cattle. CD8(+) T cell responses to these antigens were boosted in T. parva-immune cattle resolving a challenge infection and, when used to immunize naïve cattle, induced CTL responses that significantly correlated with survival from a lethal parasite challenge. These data provide a basis for developing a CTL-targeted anti-East Coast fever subunit vaccine. In addition, orthologs of these antigens may be vaccine targets for other apicomplexan parasites.Entities:
Mesh:
Substances:
Year: 2006 PMID: 16492763 PMCID: PMC1413922 DOI: 10.1073/pnas.0511273103
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205